I had no prior experience for hiring an attorney, I felt I was so lucky to meet a great one. My case last more than half year, but Sal had been always trustworthy, and caring! He was straight forward to analyze my case, and figure out several options to resolve the problems. He didn't over-promised me about the result, but the way he handle the case make me feel no fear and stress. I was placed in supervision as result, it was better than I expected. I would highly recommend Sal to anyone! - Client
Chicago Police officers have the option to issue $250 to $500 tickets to anyone caught in Chicago with 15 grams of marijuana or less. The maximum $500 fine would be assessed against anyone slapped with a second citation within a 30-day period.
Qualifying patients may possess up to 2.5 ounces of medical cannabis in a 14-day period from an authorized medical cannabis dispensary.
This fee will be established in the administrative rules being developed by the Illinois Department of Public Health. The Department has 120 days from the effective date (January 1, 2014) to develop the rules and criteria that will apply to the patient registry. At that time (approximately May 1, 2014), these rules will be filed with the Illinois General Assembly's Joint Committee on Administrative Rules (JCAR) for review and public comment.
A date has not yet been determined. The effective date of the act is January 1, 2014. Before issuing registration cards, the Illinois Department of Public Health must adopt administrative rules, set registration fees, and develop the process to receive and process registrations. Any date for issuing registry identification cards will take into account the time needed to complete these tasks.
Do not send any information at this time. The Illinois Department of Public Health is currently building the necessary infrastructure to implement the law, including the development of a registration process for patients and caregivers. The Department will issue registry identification cards to patients and designated caregivers once the administrative rules for the program are adopted.
Debilitating medical conditions include 40 chronic diseases and conditions: cancer, glaucoma, positive status for human immunodeficiency virus (HIV), acquired immunodeficiency syndrome (AIDS), hepatitis C, amyotrophic lateral sclerosis, Crohn's disease, agitation of Alzheimer's disease, cachexia/wasting syndrome, muscular dystrophy, severe fibromyalgia, spinal cord disease (including but not limited to arachnoiditis), Tarlov cysts, hydromyelia syringomyelia, Rheumatoid arthritis, fibrous dysplasia, spinal cord injury, traumatic brain injury and post concussion syndrome, Multiple Sclerosis, Arnold-Chiari malformation and Syringomelia, Spinocerebellar Ataxia (SCA), Parkinson's Disease, Tourette Syndrome, Myoclonus, Dystonia, Reflex Sympathetic Dystrophy, RSD (Complex Regional Pain Syndromes Type I), Causalgia, CRPS (Complex Regional Pain Syndrome Type II), Neurofibromatosis, Chronic inflammatory Demyelinating Polyneuropathy, Chronic Inflammatory Demyelinating Polyneuropathy, Sjogren's Syndrome, Lupus, Interstitial Cystitis, Myasthenia Gravis, Hydrocephalus, nail-patella syndrome or residual limb pain; or the treatment of these conditions.
According to the act, any person may petition the Illinois Department of Public Health to add debilitating conditions or treatments to the list of conditions included in the Compassionate Use of Medical Cannabis Pilot Program. The Department will develop a process for considering the petitions, including public notice and hearing.
Smoking medical cannabis is prohibited in any public place where an individual could reasonably be expected to be observed by others, in a health care facility or any other place where smoking is prohibited by the Smoke-free Illinois Act.
No. Only Illinois residents who meet the program requirements will qualify to participate in the Compassionate Use of Medical Cannabis Pilot Program.
No. The law does not permit the Illinois Department of Public Health to issue registry identifications cards to qualifying patients under age 18.